TABLE 4.
Anti-HCV negative | Anti-HCV positive (RNA positive and negative) | Anti-HCV and HCV RNA positive (chronic HCV) | |||
---|---|---|---|---|---|
|
|
||||
MRR (95% CI)a | P-value | MRR (95% CI)a | P-value | ||
Non-Hispanic White | |||||
| |||||
Total no. (N) | 3169 | 60 | 44 | ||
| |||||
All-cause mortality (n) | 320 | 13 | 11 | ||
| |||||
Age-and sex adjusted | 1.00 [Reference] | 3.52 (1.78–6.98) | .0003 | 4.52 (2.28–8.96) | <.001 |
| |||||
Partially adjustedb | 1.00 [Reference] | 2.30 (1.09–4.83) | .03 | 3.10 (1.53–6.29) | .002 |
| |||||
Fully adjustedc | 1.00 [Reference] | 2.04 (0.96–4.32) | .062 | 2.67 (1.28–5.56) | .009 |
| |||||
Non-Hispanic Black | |||||
| |||||
Total no. (N) | 2668 | 104 | 92 | ||
| |||||
All-cause mortality (n) | 329 | 32 | 28 | ||
| |||||
Age and sex adjusted | 1.00 [Reference] | 3.45 (2.12–5.62) | <.0001 | 3.38 (1.98–5.76) | <.001 |
| |||||
Partially adjustedb | 1.00 [Reference] | 2.63 (1.77–3.91) | <.0001 | 2.45 (1.58–3.81) | <.001 |
| |||||
Fully adjustedc | 1.00 [Reference] | 2.25 (1.39–3.63) | .001 | 2.02 (1.20–3.40) | .007 |
| |||||
Mexican Americans | |||||
| |||||
Total number (N) | 2905 | 84 | 64 | ||
| |||||
All-cause mortality (n) | 206 | 24 | 21 | ||
| |||||
Age and sex adjusted | 1.00 [Reference] | 4.25 (1.70–10.56) | .002 | 6.18 (2.52–15.14) | <.001 |
| |||||
Partially adjustedb | 1.00 [Reference] | 6.02 (2.22–16.30) | .0004 | 6.78 (2.20–20.90) | .001 |
| |||||
Fully adjustedc | 1.00 [Reference] | 6.22 (2.10–18.42) | .001 | 7.48 (2.15–26.10) | .002 |
Mortality rate ratio (95% confidence interval) versus anti-HCV negative.
Partial adjustment: demographics (age, sex, marital status, education, poverty income ratio), lifestyle (alcohol consumption, smoking status, lifetime cocaine and marijuana use, lifetime number of sexual partners), body mass index and comorbidities/viruses (cancer, diabetes, hepatitis A antibody, hepatitis E antibody).
Full adjustment factors: partial adjustment factors, liver function biomarkers (ALT, total bilirubin).